The long-standing collaboration with Bristol Myers Squibb (BMS) has been extended through 2035, broadening the scope across ...
Greetings, and welcome to the Simulations Plus Incorporated Second Quarter Fiscal Year 2026 Financial Results Conference Call. [Operator Instructions] And please note that this conference is being ...
Simulations Plus has announced strategic partnership programmes with three pharmaceutical businesses to advance AI-enabled modelling in drug development. The partnerships aim to apply AI within ...
Frequent drug price revisions in Japan are pushing companies to improve cost efficiency, reinforcing the case for outsourcing ...
CorTec GmbH today announced that the U.S. Food and Drug Administration (FDA) has accepted the company into its Total Product Life Cycle Advisory Program (TAP), recognizing the Brain Interchange™ BCI ...
Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and ...
RICHMOND, Va. — April 8, 2026 — The VCU Massey Comprehensive Cancer Center has successfully completed the inaugural funding cycle of its VCU–Sanford Burnham Prebys Drug Discovery Collaborative Program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results